Search Results
Oct 15, 2025, 08:30 ET PPL Corporation to conduct webcast on Third-Quarter 2025 Earnings Results
www.pplweb.com/investors for 90 days after the call. About PPL PPL Corporation (NYSE: PPL), based in Allentown, Pennsylvania, is a leading U.S. energy company focused on providing electricity and natural gas safely,
More news about: PPL Services Corporation
Oct 13, 2025, 08:49 ET Auction of All Manufacturing Assets from the Closure of an Injection Molding Plant and a CNC Mold Shop
TOWNSHIP, Mich., Oct. 13, 2025 /PRNewswire/ -- Maynards Group of Companies, in conjunction with PPL Auctions, will conduct a two-day public auction on November 11 and 12 at 10:00 a.m. ET, featuring all assets from the closure of Davalor
More news about: Maynards Industries
Oct 08, 2025, 08:38 ET National Energy Improvement Fund (NEIF) Acquires Full Ownership of RebateBridge™, Innovative Platform for Advance Funding on Utility and Program Rebates
founded RBFunding in 2018 and have provided over $360 million in advance funding to implementors and contractors for rebates provided by Con Edison, PECO, PPL, PSE&G, Eversource, LADWP, California TECH Clean, and other utilities and programs. "Our RebateBridge™ program accelerates
More news about: National Energy Improvement Fund
Oct 01, 2025, 09:30 ET Women in Science Demonstrating Outstanding Merits (WISDOM) to Host Second Annual Lehigh Valley Student Networking Event
"Connecting Our Talents: Women in STEM" is scheduled for Oct. 30 at the Da Vinci Science Center at PPL Pavilion ALLENTOWN, Pa., Oct.
More news about: WISDOM
Sep 30, 2025, 16:19 ET PPL Electric Utilities making necessary investments to strengthen and modernize infrastructure and expand services and support for customers
For more informationPPL Electric's distribution rate request is different from the twice-annual Price to Compare rate changes, which involve energy supply charges. PPL Electric does not mark up or profit from energy supply charges. PPL Electric remains committed to transparency
More news about: PPL Electric Utilities
Sep 25, 2025, 11:02 ET SOO GREEN SECURES FINAL MUNICIPAL FRANCHISE AGREEMENT, BRINGING PROJECT ONE STEP CLOSER TO CONSTRUCTION
electricity demand with affordable and reliable power, in addition to Copenhagen Infrastructure Partners, Siemens Energy, Jingoli Power, Prysmian Group and PPL Corporation. To learn more, visit
More news about: energyRe
Sep 17, 2025, 09:43 ET Piramal Pharma Solutions aumenta le capacità di formulazione con l'aggiunta della nuova pressa per compresse bi-strato Korsch XM-12 presso il suo stabilimento di Morpeth, Regno Unito
Inoltre una delle società associate di PPL, Abbvie Therapeutics India Private Limited – una joint venture tra Abbvie e PPL – si è affermata come una delle imprese principali nel settore farmaceutico indiano, specificamente nell'area della terapia oftalmologica. PPL inoltre detiene una partecipazione strategica
More news about: Piramal Pharma Solutions
Sep 17, 2025, 09:38 ET Piramal Pharma Solutions erweitert seine Formulierungskapazitäten mit einer neuen Korsch XM-12 Zweischichttablettenpresse im Werk Morpeth, UK
LimitedPiramal Pharma Limited (PPL, NSE: PPLPHARMA I BSE: 543635) bietet über seine 17* weltweiten Entwicklungs- und Produktionsstätten und ein weltweites Vertriebsnetz in über 100 Ländern ein Portfolio differenzierter Produkte und Dienstleistungen an. Zu PPL gehören Piramal Pharma Solutions (PPS),
More news about: Piramal Pharma Solutions
Sep 17, 2025, 09:31 ET Piramal Pharma Solutions augmente ses capacités de formulation avec l'ajout d'une nouvelle presse à comprimés bicouches Korsch XM-12 sur son site de Morpeth, au Royaume-Uni.
X À propos de Piramal Pharma LimitedPiramal Pharma Limited (PPL, NSE : PPLPHARMA I BSE : 543635) propose une gamme de produits et de services différenciés à partir de ses 17* sites de développement et de fabrication
More news about: Piramal Pharma Solutions
Sep 17, 2025, 00:58 ET PPS aumenta sus capacidades de formulación con la nueva prensa de comprimidos bicapa Korsch XM-12
Además, una de las empresas asociadas de PPL, Abbvie Therapeutics India Private Limited, una empresa conjunta entre Abbvie y PPL, se ha consolidado como uno de los líderes del mercado en el área de terapia oftalmológica en el mercado farmacéutico indio. Asimismo, PPL cuenta con una inversión minoritaria
More news about: Piramal Pharma Solutions
Sep 16, 2025, 07:33 ET Piramal Pharma Solutions Augments Formulation Capabilities with the Addition of New Korsch XM-12 Bilayer Tablet Press at its Morpeth, UK Facility
LimitedPiramal Pharma Limited (PPL, NSE: PPLPHARMA I BSE: 543635), offers a portfolio of differentiated products and services through its 17* global development and manufacturing facilities and a global distribution network in over 100 countries. PPL includes Piramal Pharma Solutions (PPS),
More news about: Piramal Pharma Solutions
Sep 16, 2025, 07:25 ET Piramal Pharma Solutions Augments Formulation Capabilities with the Addition of New Korsch XM-12 Bilayer Tablet Press at its Morpeth, UK Facility
LimitedPiramal Pharma Limited (PPL, NSE: PPLPHARMA I BSE: 543635), offers a portfolio of differentiated products and services through its 17* global development and manufacturing facilities and a global distribution network in over 100 countries. PPL includes Piramal Pharma Solutions (PPS),
More news about: Piramal Pharma Solutions
Sep 09, 2025, 08:00 ET Parento Raises $5.9M Seed II to Help Every Company Support Working Parents
Parento, the only provider of comprehensive paid parental leave (PPL) insurance with employee support services, today announced an oversubscribed Seed II funding round led by ResilienceVC. The round included participation
More news about: Parento
Sep 08, 2025, 16:30 ET Perpetua Resources Receives Preliminary Project Letter and Indicative Term Sheet from the Export-Import Bank of the United States on Potential $2 Billion Debt Financing
Preliminary Project Letter ("PPL") conveying EXIM's initial due diligence findings to Perpetua on its application for $2 billion in debt financing from EXIM for the Stibnite Gold Project ("Project"). Along with the preliminary indicative term sheet, the PPL provides a summary
More news about: Perpetua Resources Corp.
Aug 30, 2025, 10:35 ET Piramal Pharma Solutions unterstützt George Medicines bei der Entwicklung seines neuen Medikaments gegen Bluthochdruck, WIDAPLIK™ (Telmisartan, Amlodipin und Indapamid)
Limited Piramal Pharma Limited (PPL, NSE: PPLPHARMA I BSE: 543635) bietet über seine 17* weltweiten Entwicklungs- und Produktionsstätten und ein weltweites Vertriebsnetz in über 100 Ländern ein Portfolio differenzierter Produkte und Dienstleistungen an. Zu PPL gehören Piramal Pharma Solutions (PPS),
More news about: Piramal Pharma Solutions
Aug 29, 2025, 15:13 ET Piramal Pharma Solutions supporta George Medicines nello sviluppo del suo nuovo farmaco per l'ipertensione, WIDAPLIK™ (telmisartan, amlodipina e indapamide)
Inoltre una delle società associate di PPL, Abbvie Therapeutics India Private Limited – una joint venture tra Abbvie e PPL – si è affermata come una delle imprese principali nel settore farmaceutico indiano, specificamente nell'area della terapia oftalmologica. PPL inoltre detiene una partecipazione strategica
More news about: Piramal Pharma Solutions
Aug 29, 2025, 15:00 ET Piramal Pharma Solutions apoya a George Medicines en el desarrollo de su nuevo fármaco, WIDAPLIK™
Además, una de las empresas asociadas de PPL, Abbvie Therapeutics India Private Limited, una empresa conjunta entre Abbvie y PPL, se ha consolidado como uno de los líderes del mercado en el área de terapia oftalmológica en el mercado farmacéutico indio. Asimismo, PPL cuenta con una inversión minoritaria
More news about: Piramal Pharma Solutions
Aug 28, 2025, 12:03 ET Piramal Pharma Solutions Supports George Medicines in Developing its New Drug for Hypertension, WIDAPLIK™ (telmisartan, amlodipine and indapamide)
Limited Piramal Pharma Limited (PPL, NSE: PPLPHARMA I BSE: 543635), offers a portfolio of differentiated products and services through its 17* global development and manufacturing facilities and a global distribution network in over 100 countries. PPL includes Piramal Pharma Solutions (PPS),
More news about: Piramal Pharma Solutions
Aug 28, 2025, 11:58 ET Piramal Pharma Solutions Supports George Medicines in Developing its New Drug for Hypertension, WIDAPLIK™ (telmisartan, amlodipine and indapamide)
Limited Piramal Pharma Limited (PPL, NSE: PPLPHARMA I BSE: 543635), offers a portfolio of differentiated products and services through its 17* global development and manufacturing facilities and a global distribution network in over 100 countries. PPL includes Piramal Pharma Solutions (PPS),
More news about: Piramal Pharma Solutions
Aug 26, 2025, 14:04 ET Piramal Pharma pubblica il rapporto sulla sostenibilità per l'anno fiscale 2025, delineando il percorso di performance e decarbonizzazione
Inoltre una delle società associate di PPL, Abbvie Therapeutics India Private Limited – una joint venture tra Abbvie e PPL – si è affermata come una delle imprese principali nel settore farmaceutico indiano, specificamente nell'area della terapia oftalmologica. PPL inoltre detiene una partecipazione strategica
More news about: Piramal Pharma Ltd
Aug 26, 2025, 14:00 ET Piramal Pharma veröffentlicht Nachhaltigkeitsbericht für das Geschäftsjahr 2025 mit Überblick über Leistung und Dekarbonisierungsplan
Limited: Piramal Pharma Limited (PPL, NSE: PPLPHARMA I BSE: 543635) bietet über seine 17* weltweiten Entwicklungs- und Produktionsstätten und ein weltweites Vertriebsnetz in über 100 Ländern ein Portfolio differenzierter Produkte und Dienstleistungen an. Zu PPL gehören Piramal Pharma Solutions (PPS),
More news about: Piramal Pharma Ltd
Aug 26, 2025, 07:42 ET Piramal Pharma publica su informe de sostenibilidad del año fiscal 2025
Además, una de las empresas asociadas de PPL, Abbvie Therapeutics India Private Limited, una empresa conjunta entre Abbvie y PPL, se ha consolidado como uno de los líderes del mercado en el área de terapia oftalmológica en el mercado farmacéutico indio. Asimismo, PPL cuenta con una inversión minoritaria
More news about: Piramal Pharma Ltd
Aug 26, 2025, 05:03 ET Piramal Pharma Publishes FY2025 Sustainability Report, Outlining Performance and Decarbonization Glidepath
Limited: Piramal Pharma Limited (PPL, NSE: PPLPHARMA I BSE: 543635), offers a portfolio of differentiated products and services through its 17* global development and manufacturing facilities and a global distribution network in over 100 countries. PPL includes Piramal Pharma Solutions (PPS),
More news about: Piramal Pharma Ltd
Aug 26, 2025, 04:58 ET Piramal Pharma Publishes FY2025 Sustainability Report, Outlining Performance and Decarbonization Glidepath
Limited: Piramal Pharma Limited (PPL, NSE: PPLPHARMA I BSE: 543635), offers a portfolio of differentiated products and services through its 17* global development and manufacturing facilities and a global distribution network in over 100 countries. PPL includes Piramal Pharma Solutions (PPS),
More news about: Piramal Pharma Ltd
Aug 25, 2025, 06:45 ET Blue Owl and Chirisa Technology Parks Close $4 Billion Joint Venture Partnership Including Machine Investment Group for Lancaster Campus
parties also intend to fund approximately $200 million for local power grid infrastructure improvements in partnership with PPL Electric Utilities. This investment is targeted at delivering a safer, more efficient and resilient electric grid in the Lancaster
More news about: Chirisa Piscataway Inc.